BCLSI
Bain Capital Life Sciences Investors’s Xilio Therapeutics XLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.1M | Hold |
4,566,817
| – | – | 0.39% | 17 |
|
|
2025
Q1 | $3.31M | Hold |
4,566,817
| – | – | 0.49% | 18 |
|
|
2024
Q4 | $4.36M | Hold |
4,566,817
| – | – | 0.51% | 20 |
|
|
2024
Q3 | $3.6M | Buy |
4,566,817
+781,367
| +21% | +$615K | 0.37% | 22 |
|
|
2024
Q2 | $3.59M | Buy |
3,785,450
+980,037
| +35% | +$929K | 0.39% | 21 |
|
|
2024
Q1 | $3.03M | Hold |
2,805,413
| – | – | 0.24% | 25 |
|
|
2023
Q4 | $1.54M | Hold |
2,805,413
| – | – | 0.15% | 26 |
|
|
2023
Q3 | $5.92M | Hold |
2,805,413
| – | – | 0.66% | 26 |
|
|
2023
Q2 | $7.35M | Hold |
2,805,413
| – | – | 0.76% | 25 |
|
|
2023
Q1 | $8.89M | Hold |
2,805,413
| – | – | 1.11% | 24 |
|
|
2022
Q4 | $7.55M | Hold |
2,805,413
| – | – | 0.84% | 26 |
|
|
2022
Q3 | $8.16M | Hold |
2,805,413
| – | – | 0.97% | 23 |
|
|
2022
Q2 | $8.19M | Hold |
2,805,413
| – | – | 0.96% | 22 |
|
|
2022
Q1 | $19.8M | Hold |
2,805,413
| – | – | 1.93% | 14 |
|
|
2021
Q4 | $44.9M | Buy |
+2,805,413
| New | +$44.9M | 3.56% | 10 |
|